Obesity drugs were first approved to treat type 2 diabetes, but theres a growing movement to test them in type 1 diabetes, too
Published safety data from clinical trials report no significant adverse effects across all studied doses and durations
Recalls & Warnings June 20, 2003 FTC Charges Marketers of Seasilver with False and Deceptive Claims On June 19, 2003, The Federal Trade Commission (FTC) and the Food and Drug Administration (FDA) announced coordinated actions against two companies - both charged with promoting the dietary supplement "Seasilver" with unsubstantiated medical claims
Modanloo M, Shokrzadeh M (2019) Analyzing mitochondrial dysfunction, oxidative stress, and apoptosis: potential role of L-carnitine
Moreover, not all methodologies utilized in these studies are properly validated against the gold standard, i.e., the Ussing chamber, and therefore caution is needed in the interpretation of these permeability data
Zero effect on my appetite